- Home
- MRVI vs NPCT Comparison
MRVI vs NPCT Comparison
Compare MRVI & NPCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MRVI
- NPCT
- Stock Information
- Founded
- MRVI 2014
- NPCT 2020
- Country
- MRVI United States
- NPCT United States
- Employees
- MRVI N/A
- NPCT N/A
- Industry
- MRVI Biotechnology: Pharmaceutical Preparations
- NPCT Investment Managers
- Sector
- MRVI Health Care
- NPCT Finance
- Exchange
- MRVI Nasdaq
- NPCT Nasdaq
- Market Cap
- MRVI 347.5M
- NPCT 307.4M
- IPO Year
- MRVI 2020
- NPCT N/A
- Fundamental
- Price
- MRVI $2.16
- NPCT $10.69
- Analyst Decision
- MRVI Hold
- NPCT
- Analyst Count
- MRVI 10
- NPCT 0
- Target Price
- MRVI $7.59
- NPCT N/A
- AVG Volume (30 Days)
- MRVI 3.8M
- NPCT 107.1K
- Earning Date
- MRVI 05-07-2025
- NPCT 01-01-0001
- Dividend Yield
- MRVI N/A
- NPCT 9.82%
- EPS Growth
- MRVI N/A
- NPCT N/A
- EPS
- MRVI N/A
- NPCT N/A
- Revenue
- MRVI $259,185,000.00
- NPCT N/A
- Revenue This Year
- MRVI N/A
- NPCT N/A
- Revenue Next Year
- MRVI $14.59
- NPCT N/A
- P/E Ratio
- MRVI N/A
- NPCT N/A
- Revenue Growth
- MRVI N/A
- NPCT N/A
- 52 Week Low
- MRVI $2.07
- NPCT $8.58
- 52 Week High
- MRVI $11.56
- NPCT $10.63
- Technical
- Relative Strength Index (RSI)
- MRVI 28.06
- NPCT 43.96
- Support Level
- MRVI $2.07
- NPCT $10.56
- Resistance Level
- MRVI $2.43
- NPCT $10.76
- Average True Range (ATR)
- MRVI 0.20
- NPCT 0.09
- MACD
- MRVI 0.05
- NPCT -0.01
- Stochastic Oscillator
- MRVI 14.06
- NPCT 32.50
About MRVI Maravai LifeSciences Holdings Inc.
Maravai LifeSciences Holdings Inc is a life sciences company. It provides products to enable the development of drug therapies, diagnostics, and novel vaccines and supports research on human diseases. Its reportable segments are Nucleic acid production and biologics safety testing. It generates a majority of its revenue from Nucleic Acid Production and focuses on the manufacturing and sale of nucleic acid products to support the needs of customers' research, and therapeutic and vaccine programs. In addition, the segment also provides research products for labeling and detecting proteins in cells and tissue samples.
About NPCT Nuveen Core Plus Impact Fund of Beneficial Interest
Nuveen Core Plus Impact Fund is an organized, diversified, closed-end management investment company. The Fund's investment objective is to seek total return through high current income and capital appreciation, while giving special consideration to certain impact and environmental, social and governance criteria.